These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2984914

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immediate regional blood flow distribution following angiotensin converting enzyme inhibition in patients with essential hypertension.
    Ventura HO, Frohlich ED, Messerli FH, Kobrin I, Kardon MB.
    Am J Med; 1984 May 31; 76(5B):58-61. PubMed ID: 6328985
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
    Drexler H, Faude F, Winterer H, Wollschläger H, Freudenberg N, Just H.
    Z Kardiol; 1987 Aug 31; 76(8):507-13. PubMed ID: 3314215
    [Abstract] [Full Text] [Related]

  • 7. Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.
    Oren S, Messerli FH, Grossman E, Garavaglia GE, Frohlich ED.
    J Am Coll Cardiol; 1991 Apr 31; 17(5):1183-7. PubMed ID: 1826120
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Frohlich ED.
    Am J Hypertens; 1988 Jul 31; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G, Alicandri CL, Agabiti-Rosei E, Fariello R, Beschi M, Boni E, Castellano M, Moniti E, Muiesan L, Romanelli G, Zanielli A.
    Am J Cardiol; 1982 Apr 21; 49(6):1420-4. PubMed ID: 6280474
    [Abstract] [Full Text] [Related]

  • 11. Acute effects of captopril on the coronary circulation of patients with hypertension and angina.
    Daly P, Rouleau JL, Cousineau D, Burgess JH.
    Am J Med; 1984 May 31; 76(5B):111-5. PubMed ID: 6328981
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
    Levine TB, Olivari MT, Cohn JN.
    Am J Med; 1984 May 31; 76(5B):38-42. PubMed ID: 6375361
    [Abstract] [Full Text] [Related]

  • 13. Response of the systemic and pulmonary circulation to converting-enzyme inhibition (captopril) at rest and during exercise in hypertensive patients.
    Fagard R, Bulpitt C, Lijnen P, Amery A.
    Circulation; 1982 Jan 31; 65(1):33-9. PubMed ID: 6273009
    [Abstract] [Full Text] [Related]

  • 14. Regional circulatory response to converting-enzyme inhibition in congestive heart failure.
    Faxon DP, Creager MA, Halperin JL.
    Br J Clin Pharmacol; 1982 Jan 31; 14 Suppl 2(Suppl 2):179S-186S. PubMed ID: 6753899
    [Abstract] [Full Text] [Related]

  • 15. [Modification of organ perfusion by calcium blocker and converting enzyme inhibitor in the conscious rat with heart failure].
    Drexler H, Truog AG, Just H, Zelis R.
    Klin Wochenschr; 1985 Mar 15; 63(6):262-7. PubMed ID: 3887015
    [Abstract] [Full Text] [Related]

  • 16. Effects of long-term blockade of angiotensin converting enzyme with captopril (SQ14,225) on hemodynamics and circulating blood volume in SHR.
    Koike H, Ito K, Miyamoto M, Nishino H.
    Hypertension; 1980 Mar 15; 2(3):299-303. PubMed ID: 6248462
    [Abstract] [Full Text] [Related]

  • 17. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.
    Creager MA, Halperin JL, Bernard DB, Faxon DP, Melidossian CD, Gavras H, Ryan TJ.
    Circulation; 1981 Sep 15; 64(3):483-9. PubMed ID: 6266691
    [Abstract] [Full Text] [Related]

  • 18. The role of renal hemodynamics in the antihypertensive effect of captopril.
    Ando K, Fujita T, Ito Y, Noda H, Yamashita K.
    Am Heart J; 1986 Feb 15; 111(2):347-52. PubMed ID: 3511649
    [Abstract] [Full Text] [Related]

  • 19. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH, Tsao Y, Grimmer SF, Winstanley PA, Orme ML, Breckenridge AM.
    Br J Clin Pharmacol; 1987 Aug 15; 24(2):163-72. PubMed ID: 2887190
    [Abstract] [Full Text] [Related]

  • 20. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension.
    Dunn FG, Oigman W, Ventura HO, Messerli FH, Kobrin I, Frohlich ED.
    Am J Cardiol; 1984 Jan 01; 53(1):105-8. PubMed ID: 6318542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.